Evaluation of Combination Treatment Benefits of nab-Paclitaxel in Experimental Pancreatic Cancer

被引：0
|
作者：
Awasthi, N. [1 ]
Ostapoff, K. T. [1 ]
Zhang, C. [1 ]
Schwarz, M. A. [1 ]
Schwarz, R. E. [1 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2012年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S153 / S153
页数：1
相关论文
共 50 条
  • [21] Phase I study of nab-paclitaxel and gemcitabine combination in patients with advanced pancreatic cancer
    Drengler, R. L.
    Smith, L. S.
    Wood, T. E.
    Borad, M. J.
    Ramanathan, R. K.
    Laheru, D. A.
    Hidalgo, M.
    Von Hoff, D. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [22] Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer
    Hakon Blomstrand
    Ursula Scheibling
    Charlotte Bratthäll
    Henrik Green
    Nils O. Elander
    BMC Cancer, 19
  • [23] Feasibility of Combination Therapy with Nab-paclitaxel Plus Gemcitabine in Patients with Recurrent Pancreatic Cancer
    Kawaida, Hiromichi
    Kono, Hiroshi
    Amemiya, Hidetake
    Saitou, Ryou
    Yamamoto, Atsushi
    Hosomura, Naohiro
    Watanabe, Mitsuaki
    Kimura, Ayako
    Furuya, Shinji
    Shimizu, Hiroki
    Akaike, Hidenori
    Kawaguchi, Yoshihiko
    Sudo, Makoto
    Itakura, Jun
    Hayakawa, Hiroshi
    Shindo, Hiroko
    Takahashi, Ei
    Takano, Shinichi
    Fukasawa, Mitsuharu
    Ichikawa, Shintaro
    Fujii, Hideki
    Ichikawa, Daisuke
    ANTICANCER RESEARCH, 2018, 38 (11) : 6537 - 6542
  • [24] Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer
    Blomstrand, Hakon
    Scheibling, Ursula
    Bratthall, Charlotte
    Green, Henrik
    Elander, Nils O.
    BMC CANCER, 2019, 19 (1)
  • [25] Neoadjuvant nab-paclitaxel in the treatment of breast cancer
    Naoto T. Ueno
    Eleftherios P. Mamounas
    Breast Cancer Research and Treatment, 2016, 156 : 427 - 440
  • [26] Neoadjuvant nab-paclitaxel in the treatment of breast cancer
    Ueno, Naoto T.
    Mamounas, Eleftherios P.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (03) : 427 - 440
  • [27] Nab-paclitaxel plus gemcitabine in the treatment of metastatic pancreatic cancer: our experience
    Mare, M.
    Munao, S.
    Germana, S.
    Colarossi, C.
    Sciacca, D.
    Giuffrida, D.
    Giannone, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [28] Neo-adjuvant treatment in patients with pancreatic cancer with nab-paclitaxel and gemcitabine
    Pomillo, A.
    Santoro, M.
    Iuliano, E.
    Luci, M.
    Perricelli, A.
    Iuliano, F.
    Mazzulla, M. F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [29] Gemcitabine/nab-paclitaxel with pamrevlumab: a novel drug combination and trial design for the treatment of locally advanced pancreatic cancer
    Picozzi, Vincent
    Alseidi, Adnan
    Winter, Jordan
    Pishvaian, Michael
    Mody, Kabir
    Glaspy, John
    Larson, Timothy
    Matrana, Marc
    Carney, Mairead
    Porter, Seth
    Kouchakji, Elias
    Rocha, Flavio
    Carrier, Ewa
    ESMO OPEN, 2020, 5 (04)
  • [30] Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer
    De Luca, Rossella
    Blasi, Livio
    Alu, Massimiliano
    Gristina, Valerio
    Cicero, Giuseppe
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1769 - 1775
12345